16
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Human SNORA31 variations impair cortical neuron-intrinsic immunity to HSV-1 and underlie herpes simplex encephalitis

      research-article
      1 , 4 , 1 , 2 , 3 , 1 , 1 , 2 , 3 , 1 , 5 , 6 , 1 , 7 , 8 , 9 , 10 , 11 , 4 , 12 , 1 , 13 , 9 , 2 , 3 , 1 , 4 , 2 , 3 , 2 , 3 , 14 , 15 , 16 , 17 , 15 , 18 , 19 , 20 , 21 , 17 , 8 , 22 , 8 , 22 , 23 , 9 , 24 , 6 , 11 , 4 , 12 , 13 , 1 , 2 , 3 , 1 , 2 , 3 , 25 , 26 , @ , 1 , 2 , 3 , @
      Nature medicine

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          HSV-1 encephalitis (HSE) is typically sporadic. Inborn errors of TLR3- and DBR1-mediated central nervous system (CNS) cell-intrinsic immunity can account for forebrain and brainstem HSE, respectively. We report five unrelated patients with forebrain HSE, each heterozygous for one of four rare variants of SNORA31, encoding a snoRNA of the H/ACA class that are predicted to direct the isomerization of uridine residues to pseudouridine in snRNA and rRNA. We show that CRISPR/Cas9-introduced biallelic and monoallelic SNORA31 deletions render human pluripotent stem cells (hPSCs)-derived cortical neurons susceptible to HSV-1. Accordingly, SNORA31-mutated patient hPSCs-derived cortical neurons are susceptible to HSV-1, like those from TLR3- or STAT1-deficient patients. Exogenous IFN-β renders SNORA31- and TLR3- but not STAT1-mutated neurons resistant to HSV-1. Finally, transcriptome analysis of the SNORA31-mutated neurons reveal normal responses to TLR3 and IFN-α/β stimulation, but abnormal responses to HSV-1. Human SNORA31 thus controls CNS neuron-intrinsic immunity to HSV-1 by a distinctive mechanism.

          Related collections

          Most cited references42

          • Record: found
          • Abstract: found
          • Article: not found

          Pseudouridine profiling reveals regulated mRNA pseudouridylation in yeast and human cells

          Post-transcriptional modification of RNA nucleosides occurs in all living organisms. Pseudouridine, the most abundant modified nucleoside in non-coding RNAs 1 , enhances the function of transfer RNA and ribosomal RNA by stabilizing RNA structure 2–8 . mRNAs were not known to contain pseudouridine, but artificial pseudouridylation dramatically affects mRNA function – it changes the genetic code by facilitating non-canonical base pairing in the ribosome decoding center 9,10 . However, without evidence of naturally occurring mRNA pseudouridylation, its physiological was unclear. Here we present a comprehensive analysis of pseudouridylation in yeast and human RNAs using Pseudo-seq, a genome-wide, single-nucleotide-resolution method for pseudouridine identification. Pseudo-seq accurately identifies known modification sites as well as 100 novel sites in non-coding RNAs, and reveals hundreds of pseudouridylated sites in mRNAs. Genetic analysis allowed us to assign most of the new modification sites to one of seven conserved pseudouridine synthases, Pus1–4, 6, 7 and 9. Notably, the majority of pseudouridines in mRNA are regulated in response to environmental signals, such as nutrient deprivation in yeast and serum starvation in human cells. These results suggest a mechanism for the rapid and regulated rewiring of the genetic code through inducible mRNA modifications. Our findings reveal unanticipated roles for pseudouridylation and provide a resource for identifying the targets of pseudouridine synthases implicated in human disease 11–13 .
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency.

            The receptors for interferon-alpha/beta (IFN-alpha/beta) and IFN-gamma activate components of the Janus kinase-signal transducer and activator of transcription (JAK-STAT) signaling pathway, leading to the formation of at least two transcription factor complexes. STAT1 interacts with STAT2 and p48/IRF-9 to form the transcription factor IFN-stimulated gene factor 3 (ISGF3). STAT1 dimers form gamma-activated factor (GAF). ISGF3 is induced mainly by IFN-alpha/beta, and GAF by IFN-gamma, although both factors can be activated by both types of IFN. Individuals with mutations in either chain of the IFN-gamma receptor (IFN-gammaR) are susceptible to infection with mycobacteria. A heterozygous STAT1 mutation that impairs GAF but not ISGF3 activation has been found in other individuals with mycobacterial disease. No individuals with deleterious mutations in the IFN-alpha/beta signaling pathway have been described. We report here two unrelated infants homozygous with respect to mutated STAT1 alleles. Neither IFN-alpha/beta nor IFN-gamma activated STAT1-containing transcription factors. Like individuals with IFN-gammaR deficiency, both infants suffered from mycobacterial disease, but unlike individuals with IFN-gammaR deficiency, both died of viral disease. Viral multiplication was not inhibited by recombinant IFN-alpha/beta in cell lines from the two individuals. Inherited impairment of the STAT1-dependent response to human IFN-alpha/beta thus results in susceptibility to viral disease.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells

              In the course of primary infection with herpes simplex virus 1 (HSV-1), children with inborn errors of TLR3 immunity are prone to HSV-1 encephalitis (HSE) 1–3 . We tested the hypothesis that the pathogenesis of HSE involves non hematopoietic central nervous system (CNS)-resident cells. We derived induced pluripotent stem cells (iPSCs) from the dermal fibroblasts of TLR3- and UNC-93B-deficient patients and from controls. These iPSCs were differentiated into highly purified populations of neural stem cells (NSCs), neurons, astrocytes and oligodendrocytes. The induction of IFN-β and/or IFN-γ1 in response to poly(I:C) stimulation was dependent on TLR3 and UNC-93B in all cells tested. However, the induction of IFN-β and IFN-γ1 in response to HSV-1 infection was impaired selectively in UNC-93B-deficient neurons and oligodendrocytes. These cells were also much more susceptible to HSV-1 infection than control cells, whereas UNC-93B-deficient NSCs and astrocytes were not. TLR3-deficient neurons were also found to be susceptible to HSV-1 infection. The rescue of UNC-93B- and TLR3-deficient cells with the corresponding wild-type allele demonstrated that the genetic defect was the cause of the poly(I:C) and HSV-1 phenotypes. The viral infection phenotype was further rescued by treatment with exogenous IFN-α/β, but not IFN-γ1.Thus, impaired TLR3- and UNC-93B-dependent IFN-α/β intrinsic immunity to HSV-1 in the CNS, in neurons and oligodendrocytes in particular, may underlie the pathogenesis of HSE in children with TLR3 pathway deficiencies.
                Bookmark

                Author and article information

                Journal
                9502015
                8791
                Nat Med
                Nat. Med.
                Nature medicine
                1078-8956
                1546-170X
                13 November 2019
                05 December 2019
                December 2019
                23 July 2020
                : 25
                : 12
                : 1873-1884
                Affiliations
                [1. ]St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA
                [2. ]Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U.1163, Necker Hospital for Sick Children, France, EU
                [3. ]Paris Descartes University, Imagine Institute, Paris, France, EU
                [4. ]The Center for Stem Cell Biology, Sloan-Kettering Institute for Cancer Research, New York, NY, USA
                [5. ]Icahn School of Medicine at Mount Sinai, New York, NY, USA
                [6. ]Department of Microbiology-Immunology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
                [7. ]Biogen, Cambridge, MA, USA
                [8. ]Department of Infectious Diseases, Aarhus University Hospital, Aarhus N, Denmark, EU
                [9. ]Laboratory of Brain Development and Repair, The Rockefeller University, New York, NY
                [10. ]Institute for Stroke and Dementia Research, University Hospital, LMU Munich, Germany, EU
                [11. ]Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
                [12. ]Developmental Biology Program, Sloan-Kettering Institute for Cancer Research, New York, NY, USA
                [13. ]Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, USA
                [14. ]Virology Department, Paris Descartes University, Sorbonne Paris Cité University, Welfare Services Paris Hospital, Hospital Group Paris Center University, 75014 Paris, France
                [15. ]Immunology Research Laboratory, Department of Pediatrics, College of Medicine, King Saud University, Riyadh, Saudi Arabia, USA
                [16. ]Department of Infectious Diseases, Pitié-Salpêtrière Hospital, Paris, France
                [17. ]Clinical Immunology Unit, Children's Ibn Rushd Hospital and Clinical Immunology Laboratory, Inflammation and Allergy LICIA, Faculty of Medicine and Pharmacy, Hassan Ii University, Casablanca, Morocco
                [18. ]Pediatric Department, Infectious Diseases and Immunodeficiencies Unit, Porto Hospital Center, Porto, Portugal, EU
                [19. ]Department of Pediatrics, Children's Hospital Los Angeles and Keck School of Medicine, University of Southern California, CA, USA
                [20. ]Prince Naif Center for Immunology Research, King Saud University, Riyadh, Saudi Arabia
                [21. ]South Paris University Hospital, Paris Hospital Welfare Services, Department of Pediatric Neurology, Paris, France
                [22. ]Department of Biomedicine, Aarhus University, Aarhus C, Denmark, EU
                [23. ]Unit of Human Evolutionary Genetics, CNRS UMR2000, Institut Pasteur, Paris, France
                [24. ]Department of Biology, Stanford University, Stanford, CA, USA
                [25. ]Pediatric Immuno-Hematology Unit, Necker Hospital for Sick Children, AP-HP, Paris, France, EU
                [26. ]Howard Hughes Medical Institute, New York, NY, USA
                Author notes

                Author Contributions

                F.G.L., O.H., Y.S.L. performed the experiments and analyzed the data. M.L.H., O.E., T.C., M.E.C.-T., D.P., K.D., B.Z., D.G., M.F.R.-D., D.K., M.J.C., J.L.M., L.L., F.R., S.R.P., T.H.M., M.T.-L, G.A.S., L.D.N., L.S., W.G. performed the experiments. S.B. assisted with patient recruitment. R.H., B.H., N.A., Z.A., L.M., J.A.C., S.A.-M., M.T., A.A.B. contributed patient samples and collected clinical data. P.Z., G.K., Y.I., F.R., V.R., L.Q.-M., L.A. analyzed the data. J.-L.C. and S.-Y.Z. analyzed the data, supervised the research, and wrote the paper with the help of all co-authors.

                [*, ◊, $, §, &]

                Equal contribution

                Article
                NIHMS1541637
                10.1038/s41591-019-0672-3
                7376819
                31806906
                17ae2924-7bb3-49c1-b72b-f76030274621

                Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms

                History
                Categories
                Article

                Medicine
                Medicine

                Comments

                Comment on this article